ID   SSR3_RAT                Reviewed;         428 AA.
AC   P30936;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   29-MAY-2024, entry version 163.
DE   RecName: Full=Somatostatin receptor type 3;
DE            Short=SS-3-R;
DE            Short=SS3-R;
DE            Short=SS3R;
DE   AltName: Full=SSR-28;
GN   Name=Sstr3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=1279674; DOI=10.1073/pnas.89.21.10267;
RA   Meyerhof W., Wulfsen I., Schoenrock C., Fehr S., Richter D.;
RT   "Molecular cloning of a somatostatin-28 receptor and comparison of its
RT   expression pattern with that of a somatostatin-14 receptor in rat brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10267-10271(1992).
RN   [2]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF SER-341; SER-346; SER-351 AND THR-357,
RP   AND PHOSPHORYLATION AT SER-341; SER-346; SER-351 AND THR-357.
RX   PubMed=9295322; DOI=10.1074/jbc.272.38.23769;
RA   Roth A., Kreienkamp H.-J., Meyerhof W., Richter D.;
RT   "Phosphorylation of four amino acid residues in the carboxyl terminus of
RT   the rat somatostatin receptor subtype 3 is crucial for its desensitization
RT   and internalization.";
RL   J. Biol. Chem. 272:23769-23774(1997).
RN   [3]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=11134004; DOI=10.1074/jbc.m006084200;
RA   Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H.J.,
RA   Hollt V., Schulz S.;
RT   "Homo- and heterodimerization of somatostatin receptor subtypes.
RT   Inactivation of sst(3) receptor function by heterodimerization with
RT   sst(2A).";
RL   J. Biol. Chem. 276:14027-14036(2001).
CC   -!- FUNCTION: Receptor for somatostatin-14 and -28. This receptor is
CC       coupled via pertussis toxin sensitive G proteins to inhibition of
CC       adenylyl cyclase. {ECO:0000269|PubMed:11134004,
CC       ECO:0000269|PubMed:1279674}.
CC   -!- SUBUNIT: Homodimer and heterodimer with SSTR2. Heterodimerization with
CC       SSTR2 inactivates SSTR3 receptor function.
CC       {ECO:0000269|PubMed:11134004}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11134004,
CC       ECO:0000269|PubMed:9295322}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11134004, ECO:0000269|PubMed:9295322}.
CC       Note=Internalized into endoplasmic vesicles upon somatostatin-
CC       stimulation.
CC   -!- TISSUE SPECIFICITY: Densely expressed in cerebellum and at moderate
CC       levels in the amygdala, cortex, striatum, spleen, liver and pituitary.
CC       {ECO:0000269|PubMed:1279674}.
CC   -!- PTM: Phosphorylated. Phosphorylation increases upon somatostatin
CC       binding. {ECO:0000269|PubMed:9295322}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63574; CAA45130.1; -; mRNA.
DR   PIR; S30508; S30508.
DR   RefSeq; NP_598206.1; NM_133522.1.
DR   RefSeq; XP_006242028.1; XM_006241966.2.
DR   AlphaFoldDB; P30936; -.
DR   SMR; P30936; -.
DR   BioGRID; 251061; 1.
DR   STRING; 10116.ENSRNOP00000009612; -.
DR   BindingDB; P30936; -.
DR   ChEMBL; CHEMBL3340; -.
DR   DrugCentral; P30936; -.
DR   GuidetoPHARMACOLOGY; 357; -.
DR   GlyCosmos; P30936; 2 sites, No reported glycans.
DR   GlyGen; P30936; 2 sites.
DR   iPTMnet; P30936; -.
DR   PhosphoSitePlus; P30936; -.
DR   PaxDb; 10116-ENSRNOP00000009612; -.
DR   Ensembl; ENSRNOT00000009612.4; ENSRNOP00000009612.2; ENSRNOG00000007332.4.
DR   Ensembl; ENSRNOT00055055509; ENSRNOP00055045798; ENSRNOG00055032113.
DR   Ensembl; ENSRNOT00060053042; ENSRNOP00060044095; ENSRNOG00060030539.
DR   Ensembl; ENSRNOT00065056180; ENSRNOP00065046278; ENSRNOG00065032663.
DR   GeneID; 171044; -.
DR   KEGG; rno:171044; -.
DR   UCSC; RGD:620308; rat.
DR   AGR; RGD:620308; -.
DR   CTD; 6753; -.
DR   RGD; 620308; Sstr3.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00940000162038; -.
DR   HOGENOM; CLU_009579_8_1_1; -.
DR   InParanoid; P30936; -.
DR   OMA; NTSSAWP; -.
DR   OrthoDB; 5393360at2759; -.
DR   PhylomeDB; P30936; -.
DR   TreeFam; TF315737; -.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   Reactome; R-RNO-5620922; BBSome-mediated cargo-targeting to cilium.
DR   PRO; PR:P30936; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000007332; Expressed in thymus and 13 other cell types or tissues.
DR   GO; GO:0060170; C:ciliary membrane; ISO:RGD.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0097730; C:non-motile cilium; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0042923; F:neuropeptide binding; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0004994; F:somatostatin receptor activity; IEA:InterPro.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central.
DR   GO; GO:0042594; P:response to starvation; IEP:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR000586; Somatstn_rcpt.
DR   InterPro; IPR001856; Somatstn_rcpt_3.
DR   PANTHER; PTHR24229; NEUROPEPTIDES RECEPTOR; 1.
DR   PANTHER; PTHR24229:SF42; SOMATOSTATIN RECEPTOR TYPE 3; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00246; SOMATOSTATNR.
DR   PRINTS; PR00589; SOMATOSTTN3R.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..428
FT                   /note="Somatostatin receptor type 3"
FT                   /id="PRO_0000070126"
FT   TOPO_DOM        1..45
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        46..71
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        72..81
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        82..103
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        104..118
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        119..140
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        141..162
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        163..182
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        183..206
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        207..232
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        233..266
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        267..288
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        289..302
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        303..325
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        326..428
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          343..428
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        355..369
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        381..428
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:9295322"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:9295322"
FT   MOD_RES         351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:9295322"
FT   MOD_RES         357
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:9295322"
FT   CARBOHYD        18
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        31
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        117..192
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   MUTAGEN         341
FT                   /note="S->A: Impaired internalization after somatostatin
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9295322"
FT   MUTAGEN         346
FT                   /note="S->A: Impaired internalization after somatostatin
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9295322"
FT   MUTAGEN         351
FT                   /note="S->A: Impaired internalization after somatostatin
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9295322"
FT   MUTAGEN         357
FT                   /note="T->A: Reduced basal and somatostatin-induced
FT                   phosphorylation. Impaired internalization after
FT                   somatostatin binding."
FT                   /evidence="ECO:0000269|PubMed:9295322"
SQ   SEQUENCE   428 AA;  47151 MW;  BE0AA948840A9E9D CRC64;
     MAAVTYPSSV PTTLDPGNAS SAWPLDTSLG NASAGTSLAG LAVSGILISL VYLVVCVVGL
     LGNSLVIYVV LRHTSSPSVT SVYILNLALA DELFMLGLPF LAAQNALSYW PFGSLMCRLV
     MAVDGINQFT SIFCLTVMSV DRYLAVVHPT RSARWRTAPV ARMVSAAVWV ASAVVVLPVV
     VFSGVPRGMS TCHMQWPEPA AAWRTAFIIY TAALGFFGPL LVICLCYLLI VVKVRSTTRR
     VRAPSCQWVQ APACQRRRRS ERRVTRMVVA VVALFVLCWM PFYLLNIVNV VCPLPEEPAF
     FGLYFLVVAL PYANSCANPI LYGFLSYRFK QGFRRILLRP SRRVRSQEPG SGPPEKTEEE
     EDEEEEERRE EEERRMQRGQ EMNGRLSQIA QPGPSGQQQR PCTGTAKEQQ LLPQEATAGD
     KASTLSHL
//
